Skip to main content

Headlines

Bayer Stops Phase III Study Of Asundexian In Atrial Fibrillation Due To Lack Of Efficacy
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Karuna Announces Positive Results From Phase 1b BP Monitoring Trial Of KarXT In Schizophrenia
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AIM ImmunoTech Announces Positive Data From Phase 2 Study Of Ampligen In Recurrent Ovarian Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Immutep : Efti+ Keytruda Generates Excellent OS Benefit In Phase II Trial In Metastatic NSCLC
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Regeneron : Dupixent Phase 3 Results Show Sustained Efficacy For Up To One Year In Children With EoE
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Merck Reveals Positive Results From Phase 3 KEYTRUDA Trials In Various Cancers
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Takeda : Phase 3 Study Of Alofisel In Complex Crohn's Perianal Fistulas Fails To Meet Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ascentage, AstraZeneca Collaborate On Phase III Study Of Lisaftoclax Combination In CLL/SLL
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AbbVie : Phase 3 Study Of Skyrizi In Crohn's Disease Meets All Primary And Secondary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Genentech's Vabysmo Maintains Vision Improvements In Phase III Trials - Quick Facts
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Longeveron: Phase 2a Trial Validate Safety, Therapeutic Potential Of Lomecel-B In Mild Alzheimer's
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ascletis Announces Positive Interim Data From Phase IIb Expansion Cohort Of ASC22 For CHB
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ionis Reports Positive Results From Phase 3 Study Of Olezarsen In Familial Chylomicronemia Syndrome
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Roivant Reports Positive Initial Phase 1 Data For IMVT-1402
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets